Novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-HT2A receptorrelated disorders

Details for Australian Patent Application No. 2004268919 (hide)

International Classifications

Event Publications

9 March 2006 PCT application entered the National Phase

PCT publication WO2005/021505 Priority application(s): WO2005/021505

13 July 2006 Assignment before Grant

Biovitrum AB The application has been assigned to Galapagos NV

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.